Kailera Therapeutics
Tracked across 3 events · 20 articles · First seen Apr 16, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Kailera Therapeutics successfully completed its initial public offering, raising $718.8 million and listing its common stock on the Nasdaq-100 Global Select Market under the ticker symbol 'KLRA'. This event marks its transition to a publicly traded company.
Apr 16, 2026 · 8 articles
Business
Impact: Kailera Therapeutics, a NewCo company built around Jiangsu Hengrui' GLP-1 assets, successfully listed on Nasdaq-100, reflecting progress in Jiangsu Hengrui' NewCo strategy and advancing global GLP-1 portfolio development.
Apr 22, 2026 · 6 articles
Business
Impact: Kailera Therapeutics is identified as an emerging player in the development of next-generation obesity therapeutics.
May 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kailera Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard